|

楼主 |
发表于 2025-2-6 15:36:45
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-2-6 16:03 编辑 : T* d* s* R6 F e* E I" N9 O
, \5 ?1 ^/ x7 f2 k4 N3 p1 h% C3 T
今年的ISC大会Late-Breaking Science(重磅研究)已经出炉,国内单位入选情况* R/ v1 Y9 F. E5 Q; x. [
% j3 _- Z5 _1 M7 k3 N( F9 {9 \* LLB2. TransRadial versus transfemoral Arterial access for CErebral angiography
7 C& a: j4 ^6 S2 dWei Ni, Huashan Hospital, Fudan University, Shanghai, China
% o1 x/ c4 p: v, L6 r
0 |! f$ u2 _; K0 O8 Y8 z5 [- BLB17. Intensive Blood Pressure Lowering After Thrombectomy in Ischemic Stroke Patients-A Randomized Clinical Trial
$ r8 M2 L2 T/ d% SXuening Zhang, West China Hospital, Sichuan University, Chendu, China1 K: n- ^- e0 X9 H+ X) x# @: E
7 P6 h! t6 |8 }3 m
LB38. Intra-arterial Tenecteplase thrombolysis for acute LVO after successful mechanical thrombectomy recanalization (ANGEL-TNK) — A Multicenter, Prospective, Randomized, Open-label, Blinded End-point Trial
" T1 D/ T5 W1 v; ~Miao Zhongrong, Beijing Tiantan Hospital, Beijing, China
+ R; S4 M% A8 R P, N) `. N- ]! @
0 T& H. v, d8 K) m) [* `LB39. The Optimal Dosage of ADjunctive Intra-Arterial Tenecteplase following Successful Endovascular Thrombectomy in Patients with Large Vessel Occlusion Acute Ischemic Stroke (DATE) Trail
3 X, |5 ~1 o9 h2 S+ WXianhua Hou, The First Affiliated Hospital, Army Medical University, Chongqing, China
# @3 {& w6 {! l( o$ @. _1 u; O
( \$ O- y8 J/ S1 x) s L6 `LB41. Treatment with intravenous alteplase in ischemic stroke patients with onset time between 4.5 and 24 hours
$ J) }7 y& L5 v$ J AMin Lou, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China
& u: U3 L ]% |
% o( O P3 t3 d$ |LB42. Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy (PEARL): A Multicenter Randomized Trial+ _$ z+ J! ~/ Y) i4 G
Yamei Tang, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China- K3 L3 l& |0 w# b
c* l: S6 h( a+ a, i, OLB44. Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients with Type 2 Diabetes Mellitus (LAMP): A Randomized Clinical Trial) L% J: s4 S5 k8 e* d" Q. t6 R* r+ X! ~
Huili Zhu, The First Affiliated Hospital of Jinan University, Guangzhou, China
7 z4 b% |7 H% n
6 s8 }$ _0 |. _) o K' E6 b" E0 a$ QLB45. BXOS110 for Acute Ischemic Stroke Treatment (BEST): A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial/ c. d; _" ?* E/ h1 g$ d+ S
Yarong Ding, Beijing Tiantan Hospital, Beijing, China
; Z) I$ S D {. u \
3 z9 J& i% u! f祝贺以上单位!
8 C" G3 e7 o8 a( S4 ` |
|